- Cerhum SA
- Oxford Performance Materials Inc.
- Straumann Group
- MedShape, Inc.
- Renovis Surgical Technologies, Inc.
- BioArchitects
- 3D Medical Manufacturing, Inc.
- EOS GmbH
- Stratasys Ltd.
- Emerging Implant Technologies GmbH
(Note: The list of the major players will be updated with the latest market scenario and trends)
Recent Developments in 3D Medical Implants Market:
-
In February 2022- 4WEB Medical launched a new array of hyperlordotic lateral spine implants, the Hyperlordotic Lateral Spine Truss System (LSTS). The latest addition to the LTST portfolio includes 18, 24, and 30-degree lordotic angles in anterior longitudinal released procedures for spine correction.
-
In March 2022- SurGenTec, a privately held spine and orthopedic technology company based in Florida, the United States, receive a clearance from the United States Food and Drug Administration (FDA) for ION Screw, its proprietary stand-alone spine fixation implant.
The rising incidence of chronic diseases such as cardiovascular disorders, orthopaedic conditions, and neurological disorders expected to drive the demand for medical implants as they are often used for diagnosis, treatment, or monitoring. Kidney, joint, eye, and heart implants are standard medical implants among geriatric people. Furthermore, the increasing awareness regarding the availability of medical implants, the presence of advanced healthcare infrastructure, rising disposable income, and increasing consumer expenditure on healthcare are the prominent drivers that are expected to boost the adoption of medical implants among patients. Moreover, the availability of a broader range of different medical implants serves a broader need for the implants, such as cardiovascular implants, orthopaedic implants, and various other types of implants. Furthermore, the risk of complications associated with implantation procedures in the medical implant market is anticipated to hamper the target market. Medical implants offer numerous benefits, including improved quality of life and enhanced treatment outcomes, but adverse events are always possible. Infections at the implant site, implant failure due to mechanical issues or material degradation, and adverse reactions to the implant or associated medications are potential complications that can arise. These complications may lead to additional medical interventions, extended hospital stays, and increased healthcare costs. Collaborations between medical device manufacturers, healthcare providers, and research institutions offers great opportunity in medical implant market. These stakeholders can combine their expertise, resources, and knowledge to drive innovation in implantable technologies by joining forces. Collaborative measures may involve research and development activities to design and refine new implantable devices, improve existing technologies, and explore novel applications. These partnerships also facilitate the exchange of valuable insights and clinical data, enabling manufacturers to better understand the needs of healthcare providers and patients and tailor their implant solutions accordingly.